Drugs Made In America Acquisition Corp. Rights (DMAAR) is a company listed on NASDAQ. Price $0.13 (-0.79%), Market cap $0.00B, 52-week low–high $0.04 ~ $0.23.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Financial statements, price targets, institutional (13F) holdings and related news for Drugs Made In America Acquisition Corp. Rights are updated in real time on BlackAll Trade.
Drugs Made In America Acquisition Corp. Rights trades at $0.13 (-0.79%). Real-time quotes and charts are available on BlackAll Trade.
Drugs Made In America Acquisition Corp. Rights has a market cap of about $0.00B.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or oth